Pictet Asset Management (UK)’s Pacific Biosciences PACB Stock Holding History

Pictet Asset Management (UK)’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$26M	Buy	744,897 +47,379	+7%	+$1.38M	0.03%	470
2021 Q1	$23.2M	Sell	697,518 -385,899	-36%	-$13.5M	0.03%	476
2020 Q4	$28.1M	Sell	1,083,417 -877,725	-45%	-$14.9M	0.04%	420
2020 Q3	$19.4M	Buy	1,961,142 +201,185	+11%	+$1.16M	0.03%	432
2020 Q2	$6.07M	Hold	1,759,957	–	–	0.01%	637
2020 Q1	$5.38M	Buy	1,759,957 +24,124	+1%	+$98.8K	0.01%	625
2019 Q4	$8.92M	Buy	1,735,833 +251,961	+17%	+$1.28M	0.02%	617
2019 Q3	$7.66M	Buy	1,483,872 +1,452,172	+4,581%	+$8.12M	0.02%	596
2019 Q2	$192K	Buy	+31,700	New	+$222K	﹤0.01%	1003

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (UK)'s PACB Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Pacific Biosciences (PACB) stake by 6.8% in Q2 2021, buying an estimated $1.38M and bringing the position to 744,897 shares worth $26M. The position accounts for 0.03% of the portfolio, ranked #470.

Pictet Asset Management (UK) first reported a position in PACB in Q2 2019 and has held it in 9 quarters since. The position peaked at $28.1M in Q4 2020. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

Pictet Asset Management (UK) held 744,897 shares of Pacific Biosciences worth $26M as of Q2 2021.
Pictet Asset Management (UK) bought 47,379 Pacific Biosciences shares in Q2 2021, an estimated $1.38M.
Pacific Biosciences made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #470 holding.
Pictet Asset Management (UK) first reported a position in Pacific Biosciences in Q2 2019 and has held it in 9 quarters since.
Pictet Asset Management (UK)'s Pacific Biosciences position peaked at $28.1M in Q4 2020.
262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.